Voorbeelden van het gebruik van Vwf in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
IU*** human von Willebrand factor** VWF.
Not all vWF is released at one time;
Furthermore patients may develop inhibitors to FVIII and VWF.
It has no doubt VWF, isan innovation in time study.
VWF and FVIII are involved in blood clotting.
C and VWF: RCo in a vial is approximately 1:2.4.
VWF was developed in the eighties by a Dutchman A. van Vessem.
Hereditary vWD is caused by mutations that impair vWF synthesis, release, or stability.
A lack of vWF impairs platelet stickiness and clumping.
Exogenously administered human plasma-derived VWF behaves in the same way as endogenous VWF.
VWF is especially common in stationary grinding,
When infused into a haemophiliac patient, factor VIII binds to vWF in the patient' s circulation.
In addition, vWF is a carrier protein for coagulation Factor VIII necessary for blood to clot.
Immediately after release in the patient's circulation, Factor VIII binds to von Willebrand factor vWF.
As Voncento contains both FVIII and VWF, it is important to know which factor you most need.
None of the papers in this work, however, explore the contribution which psychological workrelated stress may make to the incidence of VWF in vibration-exposed workers.
The amount of VWF and FVIII you need to take
Ricky Mansfield seems to have a quantitative deficiency of the vWF protein which is affecting his platelet adhesion.
Generally, 1 IU/kg VWF: RCo raises the circulating level of VWF: RCo by 0.02 IU/ml 2.
A clinical diagnosis of von Willebrand disease is based on a specific measurement of plasma vWF concentration bound to the antigen vWF: Ag.
The replacement of VWF and FVIII by Voncento will temporarily repair the blood clotting mechanisms.
to FVIII/VWF, in which case FVIII/VWF will not work properly any more.
If a dog lacking vWF requires surgery,
Results from studies in pigs showed that the application of von Willebrand Factor(vWF, 66 I. U./ kg body weight) markedly reduced the bleeding time.
PK of single dose of 80 IU VWF: RCo/kg body weight was evaluated in paediatric subjects less than 12 years of age with severe VWD see Table below.
are point-of-care screening tests where the endpoints are prolonged in patients with platelet clumping defects and vWF deficiency.
Baseline-adjusted initial PK parameters of VWF and FVIII: C in subjects<
release as well as a reduced release of von Willebrand factor(vWF) from the vascular endothelium into the blood circulation.
Voncento 1000 IU FVIII/ 2400 IU VWF(10 ml solvent)
Staining for von Willebrand factor(vWF) showed that endothelial cells had not penetrated deeply into the tissue,